ZA200405173B - 2'-halo-3',5'-dialkoxyphen-1'yl-imino-2-imidazoline derivatives and the use thereof for the treatment of urinary incontinence. - Google Patents

2'-halo-3',5'-dialkoxyphen-1'yl-imino-2-imidazoline derivatives and the use thereof for the treatment of urinary incontinence.

Info

Publication number
ZA200405173B
ZA200405173B ZA200405173A ZA200405173A ZA200405173B ZA 200405173 B ZA200405173 B ZA 200405173B ZA 200405173 A ZA200405173 A ZA 200405173A ZA 200405173 A ZA200405173 A ZA 200405173A ZA 200405173 B ZA200405173 B ZA 200405173B
Authority
ZA
South Africa
Prior art keywords
dialkoxyphen
imino
halo
treatment
urinary incontinence
Prior art date
Application number
ZA200405173A
Other languages
English (en)
Inventor
Franz Esser
Pascale Pouzet
Naoki Ishiguro
Hisato Kitagawa
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ZA200405173B publication Critical patent/ZA200405173B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
ZA200405173A 2002-01-31 2004-06-29 2'-halo-3',5'-dialkoxyphen-1'yl-imino-2-imidazoline derivatives and the use thereof for the treatment of urinary incontinence. ZA200405173B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02002352A EP1333028A1 (en) 2002-01-31 2002-01-31 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
ZA200405173B true ZA200405173B (en) 2005-06-21

Family

ID=8185397

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200405173A ZA200405173B (en) 2002-01-31 2004-06-29 2'-halo-3',5'-dialkoxyphen-1'yl-imino-2-imidazoline derivatives and the use thereof for the treatment of urinary incontinence.

Country Status (20)

Country Link
EP (2) EP1333028A1 (xx)
JP (1) JP2005516066A (xx)
KR (1) KR20040074134A (xx)
CN (1) CN1617857A (xx)
AR (1) AR038380A1 (xx)
BR (1) BR0215560A (xx)
CA (1) CA2474588A1 (xx)
EA (1) EA200400877A1 (xx)
EC (1) ECSP045210A (xx)
HR (1) HRP20040691A2 (xx)
HU (1) HUP0402654A2 (xx)
IL (1) IL162776A0 (xx)
MX (1) MXPA04007250A (xx)
NO (1) NO20043614L (xx)
PE (1) PE20030819A1 (xx)
PL (1) PL369826A1 (xx)
TW (1) TW200418462A (xx)
UY (1) UY27628A1 (xx)
WO (1) WO2003064398A1 (xx)
ZA (1) ZA200405173B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体
US20090286829A1 (en) * 2008-05-13 2009-11-19 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
US8258167B2 (en) 2008-05-13 2012-09-04 Allergan, Inc Naphthylmethylimidizoles as therapeutic agents
US8063231B2 (en) * 2008-06-09 2011-11-22 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
EP2303264B1 (en) * 2008-06-09 2018-04-04 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions using imidazoline derivatives
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2259160A1 (de) * 1972-12-02 1974-06-06 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel
AT333749B (de) * 1974-07-03 1976-12-10 Chemie Linz Ag Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten
MTP837B (en) * 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
DE19740176C2 (de) * 1997-09-12 2000-04-06 Lemfoerder Metallwaren Ag Handschaltvorrichtung für ein Kraftfahrzeug

Also Published As

Publication number Publication date
IL162776A0 (en) 2005-11-20
EP1472231A1 (en) 2004-11-03
PL369826A1 (en) 2005-05-02
KR20040074134A (ko) 2004-08-21
JP2005516066A (ja) 2005-06-02
NO20043614L (no) 2004-08-30
EP1333028A1 (en) 2003-08-06
CA2474588A1 (en) 2003-08-07
BR0215560A (pt) 2004-12-21
EA200400877A1 (ru) 2005-02-24
HRP20040691A2 (en) 2004-12-31
TW200418462A (en) 2004-10-01
UY27628A1 (es) 2003-08-29
ECSP045210A (es) 2004-09-28
CN1617857A (zh) 2005-05-18
AR038380A1 (es) 2005-01-12
HUP0402654A2 (hu) 2005-03-29
MXPA04007250A (es) 2004-10-29
WO2003064398A1 (en) 2003-08-07
PE20030819A1 (es) 2003-10-20

Similar Documents

Publication Publication Date Title
HK1091815A1 (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
AU2001275257A1 (en) Methods and devices for the treatment of urinary incontinence
MXPA03000436A (es) Medicamentos que compreden derivados de dicianopiridina.
AP2004002997A0 (en) Heterocyclic compounds for use in the treatment ofdisorders of the urinary tract.
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
ZA200307731B (en) Use of selective COX-2inhibitors for the treatment of urinary incontinence.
NZ513650A (en) Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo
AU2003214273A8 (en) Improved system for the treatment of stress urinary incontinence
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
HUP0200738A3 (en) Method of the treatment of incontinence
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
EP1558238A4 (en) BETA-HYDROXYPHENYL ALDYLAMINE AND ITS USE FOR THE TREATMENT OF GLAUCOMA
AU2002360712A1 (en) C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
ZA200405173B (en) 2'-halo-3',5'-dialkoxyphen-1'yl-imino-2-imidazoline derivatives and the use thereof for the treatment of urinary incontinence.
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
AU2002315485A1 (en) Compositions and methods for the treatment of body weight disorders, including obesity
ZA200104117B (en) The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence.
AU2003283153A8 (en) Pharmaceutical compositions for the treatment of urinary incontinence
EE200300379A (et) Alküülfenüüliminoimidasolidiini derivaadid uriinipidamatuse ravimiseks
HUP0302245A3 (en) Novel m-amino-phenylimino-imidazolidine derivatives, their use and pharmaceutical compositions for treating urinary incontinence
AU2003298547A1 (en) 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety
AU2002350446A1 (en) Uracil derivatives and the use thereof for treating bacterial diseases